mild cognitive impairment Kleeb Bua Daeng, mild cognitive impairment
Conditions
Interventions
2 capsules 2 times a day for 90 days,2 tablets once a day
Experimental Drug,Active Comparator Drug
kbd,egb
Sponsors
CHAO PHYA ABHAI BHUBEJHR hospital foundation
Eligibility
Sex/Gender
All
Age
60 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Age 60 to 75 years 2.Diagnosed with Mild Cognitive Impairment based on standard criteria with a MoCA score of 19 to 24 points. 3.Willing to participate in the study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. History of allergy to any herbal components in the Kleeb Bua Daeng formula. 2. History of other neurological disorders such as Parkinson's disease Lewy body dementia epilepsy schizophrenia or bipolar disorder. 3. Participation in another research study within the past 30 days meaning volunteers must not be enrolled in any other research projects for at least 30 days prior to joining this study. 4. Currently receiving Alzheimer disease medications or drugs that significantly affect the central nervous system.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MoCA score 90 days MoCa test | — |
Secondary
| Measure | Time frame |
|---|---|
| AST ALT eGFR 90 days blood sample test | — |
Countries
Thailand
Contacts
Public ContactNatdanai Musigavong
ministry of public health
Outcome results
None listed